Please click
 User   Pwd      Remember
Article Search: 
BiotechEast
· Home
· About us
· Services
· FAQ
· Contact us
Info Resources
· Companies
· Institutes
· Science parks
· Life science news
· Company spotlight
· Taiwan bio report
· Feature articles
· Asia-Pacific events
· Investment corner
· Technology transfer
· Int'l biotech links
· Info resources search
· Job listings
· Log out
Partners
Previous  8 9 10 11 12 13 14 15 16 17 ... Total pages:250  Next 

Life Science News

(Taiwan) Taiwan can mass produce H7N9 vaccine: pharmaceutical company


(Focus Taiwan)

2 April, 2013
A major local pharmaceutical company could produce up to 10 million doses of H7N9 avian flu vaccine in two months, the company said Tuesday following news of two deaths in China from the disease in recent days.
More...




Life Science News

(China) A Chinese Hearing Implant Takes Aim at Cochlear


(Business Week)

28 March, 2013
After suddenly going deaf at age 30, Ke Liu, a civil servant in Chinaís eastern Jiangxi province, didnít have many options. A cochlear implant mightíve restored his hearing, but the imported device cost tens of thousands of dollars. In 2010, Ke learned about a clinical trial for an implant made by a Chinese company, Hangzhou Nurotron Biotechnology. That year he had one surgically implanted and has since recovered nearly all of his hearing. "I have my old life back," says the 38-year-old.
More...




Life Science News

(Taiwan) FEZs look to international health care


Focus Taiwan)

28 March, 2013
Taiwan is set to become an international medical tourism center under the Cabinetís free economic zone initiative, according to the ROC Department of Health March 27.
More...




Life Science News

Asia's buoyant nutraceutical market drives expansion at Vitafoods Asia exhibition


((Press release, Vitafoods 2013)

28 March, 2013
Vitafoods Asia 2013 has increased in size; the exhibition is now 15 percent bigger. Demand for space at the exhibition on 4-5 September 2013, at AsiaWorld-Expo in Hong Kong, is being fuelled by international exhibitors who are keen to get their share of the buoyant Asian nutraceutical and functional food market.




Life Science News

(Taiwan) Medigene and SynCore expand partnership for marketing Veregen in Asia, Australia and New Zealand


(BiotechEast staff)

28 March, 2013
Medigene AG and SynCore Biotechnology Co., Ltd. a member of Taiwan's Sinphar Pharmaceutical Group, announced that they have expanded their existing exclusive licensing and supply contract into new regions for the supply and marketing of the Veregen ointment for the treatment of genital warts.




Life Science News

(Taiwan) Int'l medical treatment to be part of economic zone


(China Post, Taiwan)

26 March, 2013
The Council for Economic Planning and Development (CEPD) plans to include an international medical treatment area in the proposed free economic demonstration zone to attract more vistors to Taiwan, CEPD Minister Kuan Chung-ming said yesterday.
More...




Life Science News

(China) BGI acquires genome firm in California


(China Daily)

20 March, 2013
The closing of its deal for California-based Complete Genomics Inc strengthens efforts by BGI-Shenzhen, which operates genome-sequencing centers in China, to grow in the US market for medical and research DNA testing while boosting Chinese hopes of becoming a major industry player, observers say.
More...




Life Science News

(China) Next-Gen China Syndrome


(Genetic Engineering & Biotechnology News)

18 March, 2013
BGI-Shenzhen on Monday completed its long-awaited $117.6 million acquisition of Complete Genomics, three days after the Chinese sequencing giant completed its $3.15-a-share tender offer for the California company, and some six months after the deal was first announced.
More...




Life Science News

(Taiwan) NCKU Transnational Team Reveals Mystery of Aging


(Pharmalive)

13 March, 2013
Researchers have long puzzled by the mystery of aging in humans and great efforts have been put in to the attempt of discovery of the missing link. Now a National Cheng Kung University (NCKU) transnational research team has made a new discovery of aging mechanisms.
More...




Life Science News

(Taiwan) TLC novel anti-cancer drug Lipotecan accepted into "Green Path" by China's SFDA


(BiotechEast staff)

13 March, 2013
Taiwan Liposome Company (TLC) announced Monday that its multi-mechanistic anti-cancer NCE (New Chemical Entity) Lipotecan has been accepted into the "Green Path" program by China's drug approval agency, the Chinese State Food and Drug Administration (SFDA).




Events



Sponsors

Taiwan Life Sciences Bulletin

Enter email address to receive free e-newsletter


Sample

Disclaimer and Privacy Policy